ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations.
暂无分享,去创建一个
E. Kremmer | M. Ueffing | C. Gloeckner | S. Hauck | C. Deeg | E. Kortvely | Claudia S. Alge-Priglinger | Gabriele Duetsch
[1] J. Haines,et al. Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. , 2009, Investigative ophthalmology & visual science.
[2] R. Guymer,et al. Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration (AMD). , 2009, Investigative ophthalmology & visual science.
[3] R. Hogg,et al. Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[4] C. Klaver,et al. The SERPING1 gene and age-related macular degeneration , 2008, The Lancet.
[5] S. Ennis,et al. Association between the SERPING1 gene and age-related macular degeneration: a two-stage case–control study , 2008, The Lancet.
[6] S. Fisher,et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.
[7] A. Negi,et al. Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.
[8] R. Kalluri,et al. Basement Membrane Derived Fibulin-1 and Fibulin-5 Function as Angiogenesis Inhibitors and Suppress Tumor Growth , 2008, Experimental biology and medicine.
[9] R. Roepman,et al. A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes , 2007, Proteomics.
[10] M. Stevenson,et al. Mechanisms for Hsp70 secretion: crossing membranes without a leader. , 2007, Methods.
[11] Takako Sasaki,et al. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. , 2007, Human molecular genetics.
[12] E. Stone,et al. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. , 2007, Human molecular genetics.
[13] Gonçalo R. Abecasis,et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration , 2007, Proceedings of the National Academy of Sciences.
[14] R. Klein,et al. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. , 2007, Human molecular genetics.
[15] J. Haines,et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. , 2007, Human molecular genetics.
[16] W. Nickel. Unconventional secretion: an extracellular trap for export of fibroblast growth factor 2 , 2007, Journal of Cell Science.
[17] Gary C. Brown,et al. Age-related macular degeneration: the costs to society and the patient , 2007, Current opinion in ophthalmology.
[18] H. Coxson,et al. Antielastin autoimmunity in tobacco smoking–induced emphysema , 2007, Nature Medicine.
[19] R. Timpl,et al. A Comparative Analysis of the Fibulin Protein Family , 2007, Journal of Biological Chemistry.
[20] S. Brunak,et al. Locating proteins in the cell using TargetP, SignalP and related tools , 2007, Nature Protocols.
[21] S. Fisher,et al. Case–control genetic association study of fibulin‐6 (FBLN6 or HMCN1) variants in age‐related macular degeneration (AMD) , 2007, Human mutation.
[22] S. Sivaprasad,et al. Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration , 2007, Eye.
[23] E. Stone,et al. Fibulin-5 distribution in human eyes: relevance to age-related macular degeneration. , 2007, Experimental eye research.
[24] A. Negi,et al. The Upregulation of Angiogenic Gene Expression in Cultured Retinal Pigment Epithelial Cells Grown on Type I Collagen , 2007, Current eye research.
[25] C. Barnstable,et al. HTRA1 Promoter Polymorphism in Wet Age-Related Macular Degeneration , 2006, Science.
[26] Jeremy Nathans,et al. Macular degeneration: recent advances and therapeutic opportunities , 2006, Nature Reviews Neuroscience.
[27] M. Ueffing,et al. Identification and Functional Validation of Novel Autoantigens in Equine Uveitis* S , 2006, Molecular & Cellular Proteomics.
[28] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[29] S. Fisher,et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .
[30] M. Ueffing,et al. Proteomic analysis of the porcine interphotoreceptor matrix , 2005, Proteomics.
[31] S. Sivaprasad,et al. Serum elastin-derived peptides in age-related macular degeneration. , 2005, Investigative ophthalmology & visual science.
[32] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[33] A. Bird,et al. Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. , 2004, Investigative ophthalmology & visual science.
[34] V. Sheffield,et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. , 2004, The New England journal of medicine.
[35] Francis L. Munier,et al. Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Is a Binding Partner of Epithelial Growth Factor-containing Fibulin-like Extracellular Matrix Protein 1 (EFEMP1) , 2004, Journal of Biological Chemistry.
[36] R. Klein,et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. , 2004, American journal of human genetics.
[37] P. Braghetta,et al. EMILIN-1 Deficiency Induces Elastogenesis and Vascular Cell Defects , 2004, Molecular and Cellular Biology.
[38] M. Klein,et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. , 2003, Human molecular genetics.
[39] J. Bocco,et al. In vivo expression of recombinant pregnancy‐specific glycoprotein 1a induces alternative activation of monocytes and enhances Th2‐type immune response , 2003, European journal of immunology.
[40] R. Goodyear,et al. An emilin family extracellular matrix protein identified in the cochlear basilar membrane , 2003, Molecular and Cellular Neuroscience.
[41] R. Timpl,et al. Fibulins: a versatile family of extracellular matrix proteins , 2003, Nature Reviews Molecular Cell Biology.
[42] A. Colombatti,et al. Isolation and Characterization of EMILIN-2, a New Component of the Growing EMILINs Family and a Member of the EMI Domain-containing Superfamily* , 2001, The Journal of Biological Chemistry.
[43] H. Eng,et al. Association of extracellular matrix proteins fibulin‐1 and fibulin‐2 with fibronectin in bone marrow stroma , 2000, British journal of haematology.
[44] R. Timpl,et al. Tropoelastin binding to fibulins, nidogen‐2 and other extracellular matrix proteins , 1999, FEBS letters.
[45] R. Guymer,et al. Changes in Bruch’s membrane and related structures with age , 1999, Progress in Retinal and Eye Research.
[46] H. Larjava,et al. MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? , 1998, Biochemical and biophysical research communications.
[47] T. Matise,et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. , 1998, Archives of ophthalmology.
[48] J. Felsenstein. An alternating least squares approach to inferring phylogenies from pairwise distances. , 1997, Systematic biology.
[49] B. Jungnickel,et al. Approaching the mechanism of protein transport across the ER membrane. , 1996, Current Opinion in Cell Biology.
[50] T. Sasaki,et al. Binding of mouse and human fibulin-2 to extracellular matrix ligands. , 1995, Journal of molecular biology.
[51] T Vogel,et al. Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type I repeat of thrombospondin , 1993, The Journal of cell biology.
[52] G. G. Reid,et al. Type IV collagen and laminin in Bruch's membrane and basal linear deposit in the human macula. , 1992, The British journal of ophthalmology.
[53] J. Forrester,et al. Factors affecting the migration and growth of endothelial cells from microvessels of bovine retina. , 1990, Experimental eye research.
[54] W. Spellacy,et al. Measurement of pregnancy-associated plasma proteins during human gestation. , 1974, The Journal of clinical investigation.
[55] E. Rimm,et al. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. , 2007, Archives of ophthalmology.
[56] T. Glant,et al. Appearance and persistence of fibronectin in cartilage , 2004, Histochemistry.
[57] K. Yeow,et al. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix. , 2002, Matrix biology : journal of the International Society for Matrix Biology.
[58] J. Martin,et al. Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. , 2001, Journal of the American Society of Nephrology : JASN.
[59] B S Hawkins,et al. Epidemiology of age-related macular degeneration. , 1999, Molecular vision.